FEMY
Femasys Inc.NASDAQHealthcare$0.44-2.16%ClosedMarket Cap: $12.9M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
2.90
P/S
5.52
EV/EBITDA
-0.86
DCF Value
$-3.31
FCF Yield
-187.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
-767.0%
Net Margin
-812.3%
ROE
-534.9%
ROA
0.0%
ROIC
558.6%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $813.4K | -59.6% | $-4.6M | $-4.0M | $0.02 | — |
| FY 2025 | $2.3M | 0.0% | $-17.6M | $-18.6M | $-0.47 | — |
| Q3 2025 | $729.4K | 30.8% | $-3.7M | $-4.2M | $-0.10 | — |
| Q2 2025 | $409.3K | 8.8% | $-3.9M | $-4.6M | $-0.16 | — |
| Q1 2025 | $341.3K | 65.6% | $-5.5M | $-5.9M | $-0.23 | — |
| Q4 2024 | $581.6K | 66.9% | $-4.7M | $-5.1M | $-0.22 | — |
| FY 2024 | $1.6M | 66.6% | $-17.8M | $-18.8M | $-0.84 | — |
| Q3 2024 | $554.9K | 65.6% | $-5.1M | $-5.4M | $-0.24 | — |
| Q2 2024 | $221.5K | 67.0% | $-4.5M | $-4.7M | $-0.21 | — |
| Q1 2024 | $271.1K | 67.3% | $-3.5M | $-3.6M | $-0.17 | — |
| Q4 2023 | $213.1K | 63.3% | $-4.4M | $-4.4M | $-0.20 | — |
| FY 2023 | $1.1M | 64.5% | $-14.5M | $-14.2M | $-0.93 | — |